Total Payments
$4,395
2024 Payments
$2,495
Companies
25
Transactions
140
Medicare Patients
1,207
Medicare Billing
$79,596
Payment Breakdown by Category
Food & Beverage$2,422 (55.1%)
Travel$1,973 (44.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,422 | 137 | 55.1% |
| Travel and Lodging | $1,973 | 3 | 44.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $1,973 | 3 | $0 (2024) |
| Novo Nordisk Inc | $679.20 | 44 | $0 (2024) |
| Lilly USA, LLC | $302.89 | 20 | $0 (2024) |
| PFIZER INC. | $285.02 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $192.97 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $119.97 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $101.47 | 7 | $0 (2021) |
| Esperion Therapeutics, Inc. | $98.28 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.57 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $74.99 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,495 | 31 | INTUITIVE SURGICAL, INC. ($1,973) |
| 2023 | $459.77 | 27 | Lilly USA, LLC ($125.97) |
| 2022 | $236.83 | 11 | Novo Nordisk Inc ($73.14) |
| 2021 | $315.52 | 22 | Novo Nordisk Inc ($83.50) |
| 2020 | $276.21 | 18 | Novo Nordisk Inc ($114.17) |
| 2019 | $281.54 | 21 | Novo Nordisk Inc ($172.49) |
| 2018 | $103.62 | 7 | Merck Sharp & Dohme Corporation ($36.89) |
| 2017 | $226.76 | 3 | PFIZER INC. ($114.63) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.61 | General |
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Endocrinology | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardio-renal | ||||||
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: Cardiovascular | ||||||
| 04/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Obesity | ||||||
| 03/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardio-renal | ||||||
| 03/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.80 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 360 | $56,466 | $16,352 |
| 2022 | 6 | 283 | 330 | $50,251 | $15,256 |
| 2021 | 7 | 236 | 286 | $42,815 | $22,302 |
| 2020 | 10 | 398 | 464 | $58,773 | $25,685 |
Total Patients
1,207
Total Services
1,440
Medicare Billing
$79,596
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 142 | $19,089 | $7,296 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 115 | $22,773 | $4,201 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $9,446 | $2,506 | 26.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,969 | $1,223 | 62.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $820.00 | $641.00 | 78.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $451.00 | $352.55 | 78.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $1,918 | $132.55 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 145 | $19,492 | $7,085 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 79 | $15,644 | $3,401 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $9,216 | $1,984 | 21.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 26 | $3,011 | $1,779 | 59.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $1,107 | $848.71 | 76.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,781 | $158.59 | 8.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 78 | $15,446 | $7,894 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 105 | $14,115 | $6,459 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $8,985 | $5,584 | 62.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 16 | $1,853 | $1,040 | 56.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 16 | $1,103 | $741.33 | 67.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 19 | $779.00 | $345.58 | 44.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $533.00 | $237.73 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 157 | $21,106 | $7,715 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 58 | 58 | $13,363 | $7,168 | 53.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 56 | $11,090 | $4,068 | 36.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 37 | 37 | $4,285 | $2,195 | 51.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $3,040 | $1,519 | 50.0% |
About Dr. Si Lam, DO
Dr. Si Lam, DO is a Family Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992192744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Si Lam, DO has received a total of $4,395 in payments from pharmaceutical and medical device companies, with $2,495 received in 2024. These payments were reported across 140 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,422).
As a Medicare-enrolled provider, Lam has provided services to 1,207 Medicare beneficiaries, totaling 1,440 services with total Medicare billing of $79,596. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Feasterville Trevose, PA
- Active Since 04/20/2015
- Last Updated 07/07/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992192744
Products in Payments
- Da Vinci Surgical System (Device) $1,973
- Ozempic (Drug) $239.33
- ELIQUIS (Drug) $130.92
- TRULICITY (Drug) $127.33
- Rybelsus (Drug) $125.72
- Kerendia (Drug) $119.97
- EUCRISA (Drug) $114.63
- MOUNJARO (Drug) $110.26
- Vascepa (Drug) $101.47
- BEVESPI AEROSPHERE (Drug) $100.00
- NEXLETOL (Drug) $98.28
- FARXIGA (Drug) $92.97
- Saxenda (Drug) $77.56
- Wegovy (Drug) $69.38
- JARDIANCE (Drug) $69.01
- Heplisav-B (Drug) $61.46
- CYCLOSET (Drug) $60.59
- EVENITY (Biological) $56.73
- CHANTIX (Drug) $54.20
- JANUVIA (Drug) $50.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Feasterville Trevose
John Mcdonald, D.o, D.O
Family Medicine — Payments: $9,701
Family Medicine $9,701
Alberto Larrieu, Md, MD
Family Medicine — Payments: $3,114
Family Medicine $3,114
Sean Duffy, Do, DO
Family Medicine — Payments: $2,905
Family Medicine $2,905
Dr. Gilbert Kasirsky, D.o, D.O
Family Medicine — Payments: $2,513
Family Medicine $2,513
Meredith Ray, Md, MD
Family Medicine — Payments: $1,540
Family Medicine $1,540
Douglas Kimmel, D.o, D.O
Family Medicine — Payments: $1,058
Family Medicine $1,058